Does Ozempic cause muscle loss? What the trials actually measured

GLP-1 weight loss can include lean tissue, but the viral claim that the medicine simply burns muscle is too crude. Here is what the body composition substudies really showed.

By Peptis Publication · 2026-08-21 · 6 minute read · Education only

What the substudies measured

In the STEP 1 DEXA substudy of adults without diabetes taking semaglutide 2.4 mg, total fat mass fell by 19.3%, visceral fat by 27.4% and total lean mass by 9.7%. Lean mass as a proportion of body weight actually increased by about 3 percentage points. This was a small exploratory substudy, not the main trial outcome.

In the SURMOUNT-1 DEXA substudy of tirzepatide, a set of 160 paired scans showed that roughly 75% of the weight lost was fat mass and about 25% was lean mass. A 2025 network meta-analysis of 22 randomized trials with 2,258 participants reached a similar estimate: lean mass loss was about 25% of total weight lost, while relative lean mass was not adversely changed.

Why lean mass is not the same as muscle

DEXA lean mass includes body water, organs, connective tissue, bone mineral and skeletal muscle. When lean mass falls during weight loss, some of that change is water and glycogen rather than contractile muscle tissue. This is why headlines that translate a lean mass change directly into muscle loss overstate the evidence.

A 2026 proof-of-concept clinical study added an important counterweight to alarmist messaging: people using GLP-1 medicines improved body composition without a measured deterioration in strength, even where absolute lean values declined. This does not settle the question in older or frail populations, but it shows why function needs to be measured, not assumed.

Who deserves the most attention

Concern and monitoring are most justified for adults over roughly 60 to 65, people starting treatment with low muscle mass or a long history of inactivity, people losing weight very rapidly or skipping meals, and anyone noticing declining strength, worsening balance or new difficulty with everyday tasks. Those changes deserve a conversation with your current clinician.

What actually helps

Resistance training has the strongest behavioral evidence for retaining lean tissue and strength during weight loss. In an overview of 12 systematic reviews covering 149 studies of general weight loss, resistance training reduced lean mass loss by about 0.8 kg. That evidence comes from general weight loss research rather than GLP-1 specific trials, and protein supports training but does not replace it.

What the evidence cannot tell us

  • These substudies cannot say how much of any individual lean mass change was skeletal muscle.
  • Study averages describe groups under trial conditions, not what one person should expect.
  • No supplement has been shown in a large randomized trial to prevent muscle loss specifically during semaglutide or tirzepatide treatment.

Sources

  1. Wilding et al., STEP 1, New England Journal of Medicine, 2021, dossier [1]
  2. King et al., STEP 1 DEXA substudy, 2021, dossier [11]
  3. Look et al., SURMOUNT-1 DEXA substudy, Diabetes, Obesity and Metabolism, 2025, dossier [12]
  4. Karakasis et al., network meta-analysis of 22 trials, 2025, dossier [13]
  5. Langer et al., Cell Metabolism, 2026, dossier [16]
  6. Bellicha et al., Obesity Reviews, 2021, dossier [21]

Keep reading

    Talk with your current clinician before changing medication, diet, supplements or exercise.

    Get your free continuity summary